文献速递临床生化临床免疫

脂蛋白(a)电泳与免疫测定方法在区分钙化性主动脉瓣病与冠心病风险中的评估:MESA研究

Evaluation of Lipoprotein(a) Electrophoretic and Immunoassay Methods in Discriminating Risk of Calcific Aortic Valve Disease and Incident Coronary Heart Disease: The Multi-Ethnic Study of Atherosclerosis.
PubMed 文献 · Clin Chem · 2017-09-13

本研究在MESA队列4679名基线无临床冠心病证据的参与者中,比较脂蛋白(a)质量、胆固醇含量和颗粒浓度三种测定方法与钙化性主动脉瓣病及12年冠心病风险的关联。结果显示三种方法的高Lp(a)浓度均与两种结局显著相关,但Lp(a)-C和Lp(a)-P assay定量下限高且不精密度大,限制了其研究及临床应用。

要点

  • 三种Lp(a)测定方法的高浓度均与CAVD和CHD风险显著相关。
  • 按种族分层并校正多重比较后,多数关联不再显著,仅白人CAVD关联稳健。
  • Lp(a)-C和Lp(a)-P assay定量下限高且不精密度大,限制其应用。

核心结论

  • 使用二分法统计方法时,Lp(a)-C、Lp(a)-P和Lp(a)-M与CAVD或新发CHD的关联在全部MESA样本中相似。
  • Lp(a)-C和Lp(a)-P assay的高定量下限和不精密度限制了其在本分析中的 usefulness,并可能在研究和临床环境中同样受限。

研究设计与样本

  • 研究纳入MESA队列4679名基线无临床冠心病证据的参与者。
  • 基线测量Lp(a)-M、Lp(a)-C和Lp(a)-P,采用相对风险回归和Cox比例风险分析分别评估与CAVD存在及12年CHD风险的关联。

主要发现

  • 无论采用何种方法或分析切点,在校正典型心血管危险因素后,高Lp(a)浓度均与MESA参与者的CAVD和CHD显著相关。
  • 按种族/族裔分层并校正多重比较后,多数关联不再显著,但白人CAVD关联不受方法影响(均P < 0.0001)。

关键数值与推荐

  • 白人CAVD关联在所有方法中均P < 0.0001。

临床怎么用

  • 临床解读Lp(a)结果时需注意测定方法差异,Lp(a)-C和Lp(a)-P assay的高定量下限和不精密度可能影响风险分层。
  • 在研究和临床应用中,选择Lp(a)测定方法时应考虑其定量下限和精密度对关联分析的影响。

局限性

  • Lp(a)-C和Lp(a)-P assay的定量下限较高且不精密度大,限制了其分析效用。
  • 按种族/族裔分层并校正多重比较后,多数关联不再显著,可能受样本量限制。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: A number of lipoprotein(a) [Lp(a)] analytical techniques are available that quantify distinct particle components, yet their clinical efficacy has not been comprehensively evaluated. This study determined whether Lp(a) mass [Lp(a)-M], Lp(a) cholesterol content [Lp(a)-C], and particle concentration [Lp(a)-P] differentially discriminated risk of calcific aortic valve disease (CAVD) or incident coronary heart disease (CHD) among 4679 participants of the Multi-Ethnic Study of Atherosclerosis (MESA). METHODS: Lp(a)-M, Lp(a)-C, and Lp(a)-P were measured in individuals without clinical evidence of CHD at baseline. Relative risk regression and Cox proportional analysis determined associations between Lp(a) and the presence of CAVD or 12-year risk of CHD, respectively. To control for the relatively high lower limits of quantification for Lp(a)-C and Lp(a)-P assays, the upper 25th and 15th percentiles were selected as analytical cutoff points. RESULTS: Regardless of method or analytical cutoff, high Lp(a) concentrations were significantly associated with CAVD and CHD in MESA participants following adjustment for typical cardiovascular risk factors. Stratifying by race/ethnicity rendered most associations nonsignificant after correction for multiple comparisons, but Lp(a) remained associated with CAVD in whites irrespective of method (all P < 0.0001). CONCLUSIONS: Associations of Lp(a)-C, Lp(a)-P, and Lp(a)-M with CAVD or incident CHD were similar in this entire MESA sample using a dichotomized statistical approach. However, the high lower limits of quantification and imprecision of the Lp(a)-C and Lp(a)-P assays limited their usefulness in our analyses and would likely do so in research and clinical settings.

来源:Clin Chem,查看原文。版权归原作者所有。

引用

  1. Cao J, Steffen BT, Guan W, et al. Evaluation of Lipoprotein(a) Electrophoretic and Immunoassay Methods in Discriminating Risk of Calcific Aortic Valve Disease and Incident Coronary Heart Disease: The Multi-Ethnic Study of Atherosclerosis. Clin Chem. 2017. PMID: 28904058. doi:10.1373/clinchem.2016.270751

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。